{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:55:43Z","timestamp":1781513743716,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.radonc.2026.111368","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T07:41:04Z","timestamp":1767685264000},"page":"111368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Machine learning model for predicting interfraction motion of the seminal vesicles in prostate cancer radiotherapy"],"prefix":"10.1016","volume":"216","author":[{"given":"Mitsuaki","family":"Terabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7115-4822","authenticated-orcid":false,"given":"Takeshi","family":"Kamomae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5331-3391","authenticated-orcid":false,"given":"Hajime","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risei","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0214-613X","authenticated-orcid":false,"given":"Shinji","family":"Naganawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111368_b0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"key":"10.1016\/j.radonc.2026.111368_b0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(08)61815-2","article-title":"Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7\/SFUO-3): an open randomised phase III trial","volume":"373","author":"Widmark","year":"2009","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.radonc.2026.111368_b0015","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/S0140-6736(11)61095-7","article-title":"Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial","volume":"378","author":"Warde","year":"2011","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.radonc.2026.111368_b0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/02841860410002824","article-title":"The radiobiology of prostate cancer including new aspects of fractionated radiotherapy","volume":"44","author":"Fowler","year":"2005","journal-title":"Acta Oncol Stockh Swed"},{"key":"10.1016\/j.radonc.2026.111368_b0025","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0360-3016(02)03011-0","article-title":"Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume?","volume":"54","author":"Kestin","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111368_b0030","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/cancers13040759","article-title":"Stereotactic body radiotherapy for high-risk prostate cancer: a systematic review","volume":"13","author":"Foerster","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2026.111368_b0035","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ijrobp.2010.06.026","article-title":"Residual seminal vesicle displacement in marker-based image-guided radiotherapy for prostate cancer and the impact on margin design","volume":"80","author":"Smitsmans","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111368_b0040","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ijrobp.2008.10.019","article-title":"The role of seminal vesicle motion in target margin assessment for online image guided radiotherapy (IGRT) for prostate cancer","volume":"73","author":"Liang","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111368_b0045","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.radonc.2013.09.012","article-title":"Treatment simulations with a statistical deformable motion model to evaluate margins for multiple targets in radiotherapy for high-risk prostate cancer","volume":"109","author":"Th\u00f6rnqvist","year":"2013","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2026.111368_b0050","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0360-3016(00)00518-6","article-title":"The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy","volume":"47","author":"van Herk","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111368_b0055","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111368_b0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2022.02.002","article-title":"Seminal vesicle inter- and intra-fraction motion during radiotherapy for prostate cancer: a review","volume":"169","author":"Brand","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111368_b0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0360-3016(00)00608-8","article-title":"An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer","volume":"48","author":"Yan","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111368_b0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1748-717X-7-139","article-title":"Seminal vesicle interfraction displacement and margins in image guided radiotherapy for prostate cancer","volume":"7","author":"Mak","year":"2012","journal-title":"Radiat Oncol Lond Engl"},{"key":"10.1016\/j.radonc.2026.111368_b0075","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s13014-014-0288-1","article-title":"Optimal contouring of seminal vesicle for definitive radiotherapy of localized prostate cancer: comparison between EORTC prostate cancer radiotherapy guideline, RTOG0815 protocol and actual anatomy","volume":"9","author":"Qi","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111368_b0080","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fonc.2016.00184","article-title":"The comparison of stereotactic body radiation therapy and intensity-modulated radiation therapy for prostate cancer by NCCN Risk groups","volume":"6","author":"Ricco","year":"2016","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111368_b0085","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","article-title":"Phase 3 trial of stereotactic body radiotherapy in localized prostate cancer","volume":"391","author":"Van As","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111368_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.602607","article-title":"NRG Oncology Survey on practice and technology use in SRT and SBRT delivery","volume":"10","author":"Chetvertkov","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111368_b0095","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ijrobp.2018.05.053","article-title":"Repeatability and Reproducibility of radiomic features: a systematic review","volume":"102","author":"Traverso","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111368_b0100","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1007\/s10994-021-06042-2","article-title":"Special issue on feature engineering editorial","volume":"113","author":"Verdonck","year":"2024","journal-title":"Mach Learn"},{"key":"10.1016\/j.radonc.2026.111368_b0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1023\/A:1012487302797","article-title":"Gene selection for cancer classification using support vector machines","volume":"46","author":"Guyon","year":"2002","journal-title":"Mach Learn"},{"key":"10.1016\/j.radonc.2026.111368_b0110","first-page":"1189","article-title":"Greedy function approximation: a gradient boosting machine","author":"Friedman","year":"2001","journal-title":"Ann Stat"},{"key":"10.1016\/j.radonc.2026.111368_b0115","doi-asserted-by":"crossref","unstructured":"Caruana R, Niculescu-Mizil A. An empirical comparison of supervised learning algorithms. Proc. 23rd Int. Conf. Mach. Learn., New York, NY, USA: Association for Computing Machinery; 2006, p. 161\u20138. https:\/\/doi.org\/10.1145\/1143844.1143865.","DOI":"10.1145\/1143844.1143865"},{"key":"10.1016\/j.radonc.2026.111368_b0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0360-3016(95)02081-0","article-title":"Analysis of prostate and seminal vesicle motion: implications for treatment planning","volume":"34","author":"Beard","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111368_b0125","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210521","article-title":"Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5\u2009T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer","volume":"94","author":"Mazzola","year":"2021","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2026.111368_b0130","doi-asserted-by":"crossref","first-page":"19261","DOI":"10.1038\/s41598-025-04475-6","article-title":"Effect of hydrogel rectal spacer on seminal vesicle inter-fraction motion during prostate stereotactic body radiotherapy","volume":"15","author":"Kunogi","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2026.111368_b0135","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.radonc.2015.09.031","article-title":"Impact of tumour invasion on seminal vesicles mobility in radiotherapy of prostate cancer","volume":"117","author":"van der Burgt","year":"2015","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2026.111368_b0140","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.ijrobp.2008.03.005","article-title":"What CTV-to-PTV margins should be applied for prostate irradiation? Four-dimensional quantitative assessment using model-based deformable image registration techniques","volume":"72","author":"Meijer","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111368_b0145","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.radonc.2021.12.037","article-title":"Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: a post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy","volume":"167","author":"Ma","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111368_b0150","first-page":"35","article-title":"Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: initial clinical experiences and assessment of delivered doses compared to a C-arm linac","volume":"23","author":"Dunlop","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111368_b0155","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.phro.2022.04.009","article-title":"Cone-beam computed tomography-guided online adaptive radiotherapy is feasible for prostate cancer patients","volume":"22","author":"Zwart","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111368_b0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.radonc.2011.01.027","article-title":"\u2018Plan of the day\u2019 adaptive radiotherapy for bladder cancer using helical tomotherapy","volume":"99","author":"Murthy","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111368_b0165","first-page":"59","article-title":"Online radiotherapy\u2014the paradigm shift to real-time adaptive radiotherapy","volume":"122","author":"Kalinauskaite","year":"2025","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"10.1016\/j.radonc.2026.111368_b0170","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijrobp.2017.02.089","article-title":"Exploring the Margin recipe for online adaptive radiation therapy for intermediate-risk prostate cancer: an intrafractional seminal vesicles motion analysis","volume":"98","author":"Sheng","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111368_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1337626","article-title":"Optimal planning target margin for prostate radiotherapy based on interfractional and intrafractional variability assessment during 1.5T MRI-guided radiotherapy","volume":"13","author":"Kim","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111368_b0180","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.radonc.2010.11.016","article-title":"Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study","volume":"98","author":"L\u00fctgendorf-Caucig","year":"2011","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402600006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402600006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:25:24Z","timestamp":1781511924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402600006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":36,"alternative-id":["S016781402600006X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111368","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Machine learning model for predicting interfraction motion of the seminal vesicles in prostate cancer radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111368"}}